行情

SESN

SESN

Sesen Bio, Inc.
NASDAQ

实时行情|Nasdaq Last Sale

0.8026
-0.0305
-3.66%
交易中 14:38 09/21 EDT
开盘
0.8499
昨收
0.8331
最高
0.8643
最低
0.8025
成交量
681.92万
成交额
--
52周最高
6.04
52周最低
0.7000
市值
1.57亿
市盈率(TTM)
-0.9988
分时
5日
1月
3月
1年
5年
Sesen 截止日期警报
New York, New York--(Newsfile Corp. - September 19, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the Octob...
Newsfile Corp · 2天前
塞森更新
New York, New York--(Newsfile Corp. - September 17, 2021) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the Octo...
Newsfile Corp · 3天前
Sesen Bio 新闻:Berger Montague 调查针对 Sesen Bio, Inc. (SESN) 的证券欺诈指控;首席原告截止日期为 2021 年 10 月 18 日
Philadelphia, Pennsylvania--(Newsfile Corp. - September 17, 2021) - Berger Montague is investigating securities fraud allegations against Sesen Bio, Inc. ("Sesen" or the "Company"). The Firm is investigating these claims on behalf of investors who purchase...
Newsfile · 4天前
赛森股东通知
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - September 15, 2021) - Faruqi & Faruqi, LLP, a leadi...
Newsfile · 5天前
Berman Tabacco 宣布即将为 Sesen Bio, Inc. (SESN) 重大损失的投资者提供首席原告截止日期
Boston, Massachusetts--(Newsfile Corp. - September 14, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (...
Newsfile Corp · 09/14 16:29
Sesen Bio 股价飙升; Co 发布 8K 文件,说明 NCI 试验中 12 名患者的中期分析的初步结果
https://www.sec.gov/ix?doc=/Archives/edgar/data/1485003/000148500321000188/sesn-20210910.htm
Benzinga · 09/10 16:39
BeyondSpring 下跌超过 10% 创下今年第二大亏损
BeyondSpring (BYSI -13.0%) has lost more than a tenth of its value to post its biggest intra-day drop since early August as the shares of small-cap biopharma company look set
Seekingalpha · 09/07 17:25
SESEN 截止日期警报:Faruqi & Faruqi LLP 证券诉讼合伙人 James (Josh) Wilson 鼓励在 Sesen 中遭受超过 50,000 美元损失的投资者直接与他联系以讨论他们的选择
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the October 18, 2021 deadline to seek the role of lead plaintiff in a...
GlobeNewswire · 09/05 12:33
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解SESN最新的财务预测,通过SESN每股收益,每股净资产,每股现金流等数据分析Sesen Bio, Inc.近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测SESN价格均价为2.250,最高价位3.000,最低价为1.500。
EPS
机构持股
总机构数: 122
机构持股: 7,710.36万
持股比例: 39.34%
总股本: 1.96亿
类型机构数股数
增持
31
2,869.51万
建仓
43
464.05万
减持
21
445.42万
平仓
13
280.21万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+1.31%
制药与医学研究
+0.72%
高管信息
Non-Executive Chairman/Independent Director
Jay Duker
President/Chief Executive Officer/Director
Thomas Cannell
Chief Financial Officer/Treasurer
Monica Forbes
Chief Technology Officer
Glen MacDonald
Chief Accounting Officer/Controller
Elly Ryu
General Counsel/Secretary
Mark Sullivan
Director
Peter Honig
Director
Michael Jewett
Independent Director
Carrie Bourdow
Independent Director
Jane Henderson
Independent Director
Jason Keyes
暂无数据
SESN 简况
Sesen Bio, Inc.(原名:Eleven Biotherapeutics, Inc.)是一家提供靶向蛋白疗法(TPT)平台的后期临床公司。该公司专注于开发治疗癌症的抗体药物偶联物(ADC)疗法。该公司的产品包括Vicinium、结合检查点抑制剂的Vicinium、durvalumab和VB6-845d。该公司的先导计划Vicinium是一种处于第III期开发的治疗非肌层浸润性膀胱癌(NMIBC)的融合蛋白。Vicinium靶向肿瘤细胞表面上的上皮细胞粘附分子(EpCAM)抗原,以将有效的细胞毒素假单胞菌外毒素A(ETA)直接递送至癌细胞。

微牛提供Sesen Bio Inc(NASDAQ-SESN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的SESN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易SESN股票基本功能。